Analyst Research
| Report Title | Price |
|---|---|
|
Provider: Pechala's Reports
|
$15.00
|
|
Provider: Reuters Investment Profile
|
$20.00
|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: ValuEngine, Inc.
|
$127.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Masimo Corporation Raises FY 2012 Revenue Guidance; Lowers FY 2012 EPS Guidance
Masimo Corporation updated its fiscal 2012 guidance and now expects total revenue of approximately $494 million, including $466 million in product revenue this compares to prior guidance of $458 million in product revenue and $28 million in royalty revenue and $28 million in royalty revenue and expects GAAP earnings per share (EPS) to be approximately $1.11, compared to prior guidance of approximately $1.15. According to I/B/E/S Estimates, analysts were expecting the Company to report revenue of $485 million and EPS of $1.14 for fiscal 2012.
Latest Developments for Masimo Corp
Latest Key Developments in Medical
- Share this
- Link this
- Digg this


Follow Reuters